Cancard
Cancard is a UK company offering annual membership ID cards (£29 first year, £19 renewal) to medical cannabis patients, serving 100,000+ members. Backed by the National Police Chiefs' Council, it provides 24/7 police verification, advocacy during stops, and housing/social services support.
- Company typePrivate
- Founded2018
- HeadquartersLondon, United Kingdom
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Cancard does
Cancard Ltd is a privately-held UK company founded in 2018 that issues identification cards to patients who consume cannabis for medical reasons under a private prescription. The company is headquartered in London, operates as a private limited company with 1–10 employees, and serves a community of over 100,000 patients across England, Scotland, and Wales (with Northern Ireland pending Police Service of Northern Ireland confirmation). The core product is a physical and digital ID card bearing the holder's name, photograph, and a unique verification number, paired with a complementary mobile application and a 24/7 police verification helpline (0333 443 4444). The card functions as a validated indication to police and third parties that the holder has a medically diagnosed condition qualifying for cannabis prescription, and is formally backed by the National Police Chiefs' Council (NPCC), which has briefed every UK police force on the scheme. According to the company, 98.2% of police stops involving Cancard holders result in no further action.
The underlying technology is a relatively straightforward verification infrastructure: physical cards with QR codes, NFC/RFID tags, a digital app for account management and prescription upload, and a staffed contact centre for police verification. The technical moat is less about product sophistication and more about the institutional position — co-design with senior police and legal advisors, formal NPCC recognition, and an established police verification protocol — that competitors cannot easily replicate. The company is GDPR compliant, holds a registered CANCARD™ trademark, and has built a multi-stakeholder advocacy ecosystem spanning police bodies (Police Federation, Police Foundation), legal partners (Mackrell Solicitors, Red Lion Chambers), private cannabis clinics (Integro, Curaleaf, Lyphe), and patient advocacy organisations (PLEA, Volteface, The Centre for Medicinal Cannabis).
Cancard operates a subscription-based revenue model with a single primary stream: annual membership fees of £29 in the first year and £19 on renewal, with subsidized memberships available for low-income applicants. Distribution is entirely self-serve through the online application portal (app.cancard.co.uk), supplemented by referrals from partner clinics and organic community-driven growth. The company has no disclosed external funding, operates without a parent company, and has filed no public funding rounds. The 2025 relaunch expanded the scope beyond police stops to include formal advocacy and mediation services for housing disputes, social services interactions, and child custody cases, broadening the addressable use cases and the stakeholder surface.
Cancard firmographics
Firmographics- Name
- Cancard
- Legal name
- Cancard Ltd
- Website
- https://cancard.co.uk
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Cancard is a UK company offering annual membership ID cards (£29 first year, £19 renewal) to medical cannabis patients, serving 100,000+ members. Backed by the National Police Chiefs' Council, it provides 24/7 police verification, advocacy during stops, and housing/social services support.
- Ownership category
- akta.pro rank
Where Cancard is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
Cancard business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Annual Membership Fee: Primary revenue stream from annual subscription for Cancard membership card. First year £29, renewal £19 per year. Subsidized memberships available for low-income applicants.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Standard annual membership |
| Subscription | Annual | Subsidized membership |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels10 records
Cancard product offering
Product offeringCore offering
Cancard issues a medical ID card for UK patients who consume cannabis medicinally with a private prescription (or qualifying diagnosis). The card serves as a validated indication to police and third parties that the holder has a legitimate medical need, backed by a 24/7 police verification helpline and real-time advocacy support during police stops, housing issues, and social service interactions.
Product overview
Cancard is a unified medical identification card system for UK medical cannabis patients, providing a physical and digital ID card backed by NPCC-recognized police verification services. The core product includes the Cancard itself, a companion mobile app for account management and verification, a 24/7 police verification hotline, and access to a clinic directory for connecting patients with private cannabis prescription services. Two card designs are currently in circulation: the original blue Classic card and the newer black/yellow design.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancard Medical ID Card A physical and digital medical ID card displaying patient name, photo, and unique verification number. Serves as a validated indication to police and third parties that the holder consumes cannabis medicinally. Backed by NPCC with 24/7 verification support and used by over 100,000 UK patients.
- Cancard Mobile App
Quantifiable outcome
- 98.2% of police stops result in no further action
- +3 more outcomes
Companies that use Cancard
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles4 records
Cancard technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cancard partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- National Police Chiefs' Council (NPCC)coreNPCC has formally briefed every UK police force about Cancard. Provides national framework for police discretion when encountering medical cannabis patients with valid Cancard. Officers can verify cards 24/7 via dedicated helpline.
- Police FederationcorePolice Federation supports Cancard scheme and has helped brief police officers across the UK on the scheme and verification process.
- Police FoundationcorePolice Foundation research organization supports Cancard and has been involved in briefings and scheme development.
- Mackrell SolicitorscoreLegal support partner providing legal advice helpline for Cancard members. Assisted with landmark Andy Baines case. Available for member consultations.
- Curaleaf ClinicminorPrivate cannabis clinic recommending Cancard to patients as additional verification and protection alongside private prescriptions.
- Lyphe ClinicminorPrivate cannabis clinic recommending Cancard to patients as additional verification and protection alongside private prescriptions.
- Integro Medical ClinicsminorPrivate cannabis clinic recommending Cancard to patients as additional verification and protection alongside private prescriptions.
- PLEAminorPatient advocacy organization advocating for quality of life with medicinal cannabis. Provides resources and support referrals for Cancard community.
- VapefiendminorVapouriser supplier recommended by Cancard for harm reduction. Provides patient discounts or recommendations for quality vaporizing equipment.
- The Centre for Medicinal CannabisminorUK industry body for medicinal cannabis sector supporting Cancard's mission and patient advocacy efforts.
- Grow BiotechminorBiotechnology company in cannabis space supporting Cancard and patient access initiatives.
- VoltefaceminorDrug policy reform organization supporting Cancard's mission and advocacy work.
- SeedsmanminorCannabis seed company supporting patient access and advocacy.
- Columbia CareminorLicensed cannabis company supporting Cancard patient community.
- Red Lion ChambersminorChambers of barristers providing legal support and advice for Cancard members.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
Cancard competitors and assessment
Company assessmentOthers
- The Centre for Medicinal Cannabis: The CMC is the UK's industry body for the medicinal cannabis sector, supporting Cancard and broader patient access. Comparable as an ecosystem stakeholder and policy advocate in the UK medical cannabis space, but operates as a trade body rather than a direct service provider.
- Volteface: Volteface is a UK drug policy reform organization that supports Cancard's advocacy mission. Comparable as a UK cannabis policy and patient advocacy peer, but operates as a think tank rather than a direct-to-patient service.
- PLEA (Patient Led Engagement for Access): PLEA is a UK patient advocacy organization for medicinal cannabis users and a Cancard affiliate. Comparable as a peer in UK medical cannabis patient advocacy and education, though focused on community support rather than ID verification.
Regional players
- Medical Cannabis Clinics Australia: An Australian cannabis clinic network providing patient consultations and medicinal cannabis prescriptions. Comparable to Cancard's partner clinics (Integro, Curaleaf, Lyphe) as a regional prescription access channel for medical cannabis patients, but serves a different geography.
Direct peers
- Integro Medical Clinics: Integro is a UK private cannabis clinic issuing medical cannabis prescriptions and referring patients to Cancard for additional protection. Comparable as a UK medical cannabis patient service provider, though focused on prescription rather than verification advocacy.
- Veriheal: Veriheal is a US-based cannabis patient certification platform that connects patients with physicians and helps them obtain state-issued medical marijuana cards. It is comparable to Cancard as a digital-first cannabis patient ID and access service targeting patients navigating legal and medical cannabis frameworks.
- Leafwell: Leafwell is a leading medical cannabis card and telemedicine platform operating across multiple US states and the UK. It directly parallels Cancard's model of issuing patient medical cannabis cards, providing physician consultations, and verifying patient status for legal protection.
- Lyphe Clinic: Lyphe is a UK private medical cannabis clinic that prescribes cannabis and recommends Cancard to its patients. It is comparable as a UK cannabis patient access point but differs in being a prescription-issuing clinic rather than a verification/advocacy card provider.
- NuggMD: NuggMD is a US medical cannabis telemedicine and card-recommendation service offering online evaluations for medical marijuana cards across multiple states. Comparable to Cancard as a self-serve, technology-driven patient certification and ID verification platform.
Broad incumbents
- Curaleaf International: Curaleaf is a major US-listed cannabis operator with international presence and a UK clinic arm that prescribes medical cannabis. Comparable to Cancard as a channel partner in the UK medical cannabis ecosystem, but operates at much broader scale across cultivation, retail, and patient services.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Cancard social profiles
Digital presenceCancard compliance and trust
Trust signalCompliance1 record
Cancard financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cancard leadership team
Management profileNumber of profiles
Profiles1 record
Cancard funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cancard M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cancard
What does Cancard do?
Cancard issues a medical ID card for UK patients who consume cannabis medicinally with a private prescription (or qualifying diagnosis). The card serves as a validated indication to police and third parties that the holder has a legitimate medical need, backed by a 24/7 police verification helpline and real-time advocacy support during police stops, housing issues, and social service interactions.
Is Cancard a public or private company?
Cancard is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cancard founded?
Cancard was founded in 2018. It employs 1 to 10 people.
Where is Cancard based?
Cancard is headquartered in London, United Kingdom, in the Europe region.
How does Cancard make money?
One revenue line is on record: annual Membership Fee.
Who are Cancard's main competitors?
Others on record are The Centre for Medicinal Cannabis, Volteface and PLEA (Patient Led Engagement for Access). Medical Cannabis Clinics Australia is listed as a regional player. Direct peers are Integro Medical Clinics, Veriheal, Leafwell, Lyphe Clinic and NuggMD. Curaleaf International is listed as a broad incumbent.
Does Cancard have an API?
No public API is recorded for Cancard.